Fragmin Articles
Japan stock market week to Sept 8, 2008
15 September 2008
Daiichi Sankyo reports on Factor Xa inhibitor
8 September 2008
GSK'a Arixtra cleared in EU
18 July 2005
Arixtra prevents VTE in surgery patients
28 July 2003
Pharmacia starts new study of LMWH drug
1 November 2001
SkyePharma wins FDA approval for Solaraze
25 October 2000
Pharmacia's Fragmin label revised
8 August 2000
AstraZeneca's reveals new anticoagulant data
8 May 2000
Aspirin as effective as dalteparin in stroke prevention
13 April 2000
Weston looking to raise L50 million
28 March 2000
Pharmacia & Upjohn and Monsanto both post strong results for 1999
11 February 2000
P&U continues turnaround, looking for 1999 double-digit growth
29 October 1999
DuPont files for new LMWH in USA (updated)
6 July 1999
Fragmin cleared for angina in USA
3 June 1999
P&U pursues novel antibiotics in $30m deal
7 April 1999
P&U posts strong growth for 1998
12 February 1999
Bioject - one step ahead in a needle-free world
10 February 1999
Weston Medical signs Intraject deal with P&U
4 February 1999
P&U Sales Up, Says Turnaround Is On Track
30 April 1998
R-PR's Lovenox Cleared In USA For Angina
31 March 1998
1998 - A "Critical" Year For P&U, Says CEO
3 December 1997
Normiflo Launched In USA; First Market
7 August 1997
First Approval Of Wyeth's LMWH Normiflo
9 June 1997
Fragmin Licensed For Unstable CAD
10 March 1997
Net Income Falls At Pharmacia & Upjohn
12 August 1996
Pharmacia And Kissei To Copromote Fragmin
29 April 1996
EUROPE STOCK COMMENT
11 March 1996
Pharmacia & Upjohn First Combined Results
26 February 1996
Pharmacia Sees Downturn In Last Independent Results
20 November 1995
Planning For Success In An Uncertain Japan
2 October 1995
Marriage Of Pharmacia And Upjohn Will Create New $13 Bill Drug Group
4 September 1995
FRISC Trial Casts Light On Antithrombotic Use
4 September 1995
Early FRIC Data Back Fragmin Use In UA
4 September 1995
Pharmacia Licenses Tolterodine To Kissei
31 July 1995
Pharmacia Results Down But Ahead Of Expectations
22 May 1995
Productivity Improvements Boost Pharmacia Earnings
20 March 1995
Fragmin Approved In USA
9 January 1995
Pharmacia's Sales Decline But Profits Rise
21 November 1994
Fragmin Sales
7 November 1994
Pharmacia's Fragmin After Bypass Grafting
10 October 1994
Kissei Sales Better Than Expected
3 October 1994
2.8 Bill Kroner Interim Profits For Pharmacia
5 September 1994
Bezatol And Fragmin Boosts Kissei Sales
18 July 1994
NEW HORIZONS FOR THE USE OF LMW HEPARIN
30 May 1994
PHARMACIA OPERATING INCOME ROCKETS
23 May 1994
CURRENCY CHANGES HELP PHARMACIA
21 March 1994
FRAGMIN APPROVABLE, SAYS FDA
24 January 1994
PROCORDIA/KABI PHARMACIA PROFITS UP
22 March 1993
FRAGMIN SAFER THAN STANDARD HEPARIN
8 February 1993
STOCK MARKET COMMENTARY: TOKYO
20 April 1992
Showing 1-62 of 62 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
